TrialRheumatology (Oxford, England)2025

Predictors of response to intravenous immunoglobulin in patients with dermatomyositis: the ProDERM study.

Christina Charles-Schoeman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.